{"id":177159,"date":"2026-08-13T08:40:13","date_gmt":"2026-08-13T08:40:13","guid":{"rendered":"https:\/\/pabau.com\/?p=177159"},"modified":"2026-08-13T08:40:16","modified_gmt":"2026-08-13T08:40:16","slug":"hcpcs-code-j0885","status":"publish","type":"post","link":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/","title":{"rendered":"HCPCS Code J0885: Epoetin alfa billing guide for non-ESRD use"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"HCPCS Code J0885: Epoetin alfa billing guide for non-ESRD use\",\"description\":\"HCPCS Code J0885 covers epoetin alfa injections for non-ESRD use, billed per 1,000 units. Learn indications, modifiers, ICD-10 crosswalk, and Medicare coverage criteria.\",\"url\":\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0885\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-08-10\",\"dateModified\":\"2026-08-13\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>HCPCS code J0885 covers injection of epoetin alfa for non-ESRD use, billed per 1,000 units administered.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Medicare Part B pays J0885 at ASP plus 6%, and dialysis-dependent ESRD patients bill under Q4081 instead.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>The three ESA codes carry three different unit descriptors, which is where most units errors start.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Every claim needs a documented baseline hemoglobin, a covered ICD-10-CM diagnosis, and a signed order naming dose and route.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Practice management software like Pabau checks J0885 units and modifiers before a claim leaves the office.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">HCPCS code J0885 is the Level II code for injection of epoetin alfa in non-ESRD patients, billed per 1,000 units. It covers Epogen, Procrit, and the biosimilar Retacrit when the patient is not on dialysis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Most J0885 denials start with the unit descriptor. Epoetin alfa is billed per 1,000 units under J0885 and per 100 units under Q4081. Darbepoetin alfa, a different drug, is billed per microgram. Carry the math from one code to another and the claim is wrong before it leaves the office.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This guide covers the official descriptor, clinical indications, the units calculation, modifiers, the ICD-10-CM crosswalk, Medicare coverage, and documentation requirements.<\/p>\n\n\n\n<h2 id=\"h-hcpcs-code-j0885-definition-and-code-details\" class=\"wp-block-heading\">HCPCS Code J0885: Definition and code details<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">HCPCS code J0885 is the Level II code for: <em>Injection, epoetin alfa, (for non-ESRD use), per 1,000 units.<\/em> It covers the erythropoiesis-stimulating agent (ESA) epoetin alfa, marketed as Epogen (Amgen) and Procrit (Janssen). It also covers the FDA-approved biosimilar Retacrit (epoetin alfa-epbx, Pfizer).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The non-ESRD qualifier is the defining clinical criterion. Dialysis-dependent patients have their own separate code, and using J0885 for one of them is a denial waiting to happen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">According to the <a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/healthcare-common-procedure-system\" target=\"_blank\" rel=\"nofollow noopener\">CMS HCPCS Level II coding system<\/a>, J0885 is a drug administration code in the J-code series, maintained annually by CMS. It is billed under Medicare Part B and reported on professional claims (CMS-1500) and outpatient institutional claims (UB-04).<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J0885<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Official descriptor<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, epoetin alfa, (for non-ESRD use), per 1,000 units<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code type<\/td>\n<td style=\"padding:12px 16px;color:#374151\">HCPCS Level II drug administration (J-code)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Drug names<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Epogen (Amgen), Procrit (Janssen), Retacrit biosimilar (Pfizer)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billing unit<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 1,000 units administered<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Medicare benefit<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Part B (physician office, hospital outpatient)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Patient population<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-ESRD patients only (non-dialysis)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<h2 id=\"h-clinical-indications-when-to-use-j0885\" class=\"wp-block-heading\">Clinical indications: When to use J0885<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J0885 applies to non-dialysis patients only. Medicare&#8217;s Local Coverage Determinations (LCDs) list two primary covered indications. They are chemotherapy-induced anemia and anemia of chronic kidney disease (CKD) in patients not yet on dialysis.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Chemotherapy-induced anemia (CIA):<\/strong> Patients receiving myelosuppressive chemotherapy for non-myeloid malignancies, where the hemoglobin (Hgb) falls below the CMS threshold. Therapy exists to reduce transfusions during the chemotherapy course, so coverage ends when that course ends.<\/li>\n\n\n\n<li><strong>Anemia of non-dialysis CKD:<\/strong> Patients with chronic kidney disease who are not receiving dialysis, sometimes called pre-dialysis or non-ESRD CKD. These patients are treated in outpatient nephrology or <a href=\"https:\/\/pabau.com\/industry\/gp-clinic-software\/\">primary care practices<\/a>, not dialysis facilities.<\/li>\n\n\n\n<li><strong>Anemia in HIV-infected patients:<\/strong> Medicare covers epoetin alfa for anemia related to AZT (zidovudine) therapy in HIV-positive patients, subject to specific hemoglobin and dosing criteria.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">J0885 is <strong>not<\/strong> appropriate for dialysis-dependent ESRD patients. Those patients bill under Q4081, which covers epoetin alfa for ESRD dialysis in any setting. Mixing the two codes is one of the most audited errors in ESA billing.<\/p>\n\n\n\n<h2 id=\"h-how-to-calculate-the-units-you-bill\" class=\"wp-block-heading\">How to calculate the units you bill<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The per-1,000-units structure trips up billing teams used to flat-dose codes. Units billed must reflect the dose actually administered, rounded according to CMS rounding guidelines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Calculation formula:<\/strong> divide the dose administered in units by 1,000. The result is the number of billing units you report in the units field.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Dose administered<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Units to bill (J0885)<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Common mistake<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">10,000 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">10<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Billing 1 unit (flat dose)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">20,000 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">20<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Billing 2 units (per vial, not per 1,000)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">40,000 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">40<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Billing 4 units (per vial)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">3,000 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">3<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Billing 1 unit (rounding up to nearest vial)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Verify the ordered dose in the physician&#8217;s order or administration record before billing. The units billed must match the documented dose exactly, not the vial size purchased. Using vial size instead of administered dose is the single most common J0885 units error.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The same discipline applies to every J-code on your fee schedule. Codes such as <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j1364\/\">J1364<\/a> and <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0600\/\">J0600<\/a> carry their own descriptors, so read the descriptor before you divide.<\/p>\n\n\n\n<h2 id=\"h-modifiers-that-belong-on-the-claim\" class=\"wp-block-heading\">Modifiers that belong on the claim<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Modifiers signal the route of administration and the drug source. Most payers require at least one route modifier on every J0885 claim.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Modifier<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">When to use<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JA<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Intravenous (IV) administration<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Drug given IV push or infusion<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JB<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Subcutaneous (SC) administration<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Drug injected subcutaneously<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">EY<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No physician order on file<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Claim submitted without required order; signals medical necessity review<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">GZ<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Item or service expected to be denied as not reasonable or necessary<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Used when Hgb exceeds threshold but the service still goes ahead<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">GA<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Waiver of liability on file<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ABN signed by patient; protects provider on likely-denial claims<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">JA and JB are mutually exclusive, so use one per claim line. In an <a href=\"https:\/\/pabau.com\/industry\/iv-therapy-emr-software\/\">IV therapy practice<\/a> JA is the usual default, but the administration record still has to confirm the route. Commercial payers vary, so check the plan&#8217;s billing guide before submitting.<\/p>\n\n\n\n<h2 id=\"h-icd-10-cm-codes-that-support-medical-necessity\" class=\"wp-block-heading\">ICD-10-CM codes that support medical necessity<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medical necessity for J0885 must be supported by a covered ICD-10-CM diagnosis code. CMS LCDs list the covered conditions, and claims without a matching diagnosis are denied outright. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The <a href=\"https:\/\/www.aapc.com\/codes\/hcpcs-codes-range\/\" target=\"_blank\" rel=\"nofollow noopener\">AAPC HCPCS code lookup<\/a> includes crosswalk tables linking J0885 to supported diagnosis codes.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-10-CM code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Indication<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D63.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Anemia in neoplastic disease<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Cancer-related anemia (chemotherapy-induced)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D63.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Anemia in chronic kidney disease<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-dialysis CKD anemia<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">N18.1-N18.5<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Chronic kidney disease, stages 1-5 (non-ESRD)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Primary CKD diagnosis to pair with D63.1<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">B20<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Human immunodeficiency virus (HIV) disease<\/td>\n<td style=\"padding:12px 16px;color:#374151\">AZT-related anemia in HIV patients<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D64.81<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Anemia due to antineoplastic chemotherapy<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Chemotherapy-induced anemia (alternative code)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Always list the underlying malignancy or CKD stage code alongside the anemia code. A standalone D63.0 without the neoplasm diagnosis is a common cause of medical necessity denials.<\/p>\n\n\n\n<h2 id=\"h-medicare-coverage-and-the-fee-schedule\" class=\"wp-block-heading\">Medicare coverage and the fee schedule<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medicare Part B covers J0885 under the drug reimbursement methodology. Payment is set at <strong>ASP+6%<\/strong> (Average Sales Price plus 6%), updated quarterly. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Because the rate moves every quarter, verify it with the <a href=\"https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search\/overview\" target=\"_blank\" rel=\"nofollow noopener\">CMS Physician Fee Schedule lookup tool<\/a> rather than trusting a fixed dollar figure.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">CMS hemoglobin thresholds govern whether therapy may continue. Under current LCD guidance, ESA therapy should generally be withheld once Hgb reaches 11 g\/dL in CKD patients. It should not be used to target Hgb above 11 g\/dL in chemotherapy patients either.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Those thresholds reflect the FDA black box warning on ESAs. The warning flags increased risk of death, myocardial infarction, stroke, venous thromboembolism, and tumor progression at higher hemoglobin targets.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Check the CMS ASP Drug Pricing File every quarter. CMS publishes it each January, April, July, and October. A claim submitted on an outdated rate may be underpaid or flagged for review. Set a calendar reminder tied to the CMS release schedule and update your billing system before claims go out.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-documentation-requirements\" class=\"wp-block-heading\">Documentation requirements<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Inadequate documentation is the number-one reason J0885 claims clear adjudication and then fail on audit. The medical record has to support every element of medical necessity before the claim goes out. Keeping <a href=\"https:\/\/pabau.com\/blog\/medical-forms-at-your-healthcare-practice\/\">medical forms for your practice<\/a> in a structured EHR reduces that audit exposure.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Baseline hemoglobin or hematocrit:<\/strong> Document the Hgb or Hct result that triggered therapy, with the collection date.<\/li>\n\n\n\n<li><strong>Confirmed diagnosis:<\/strong> The chart must include the covered ICD-10-CM diagnosis, such as D63.1 paired with a CKD stage code. A clinical note referencing anemia is not enough.<\/li>\n\n\n\n<li><strong>Physician order:<\/strong> A signed order specifying the drug, dose, frequency, and route of administration. Absence of a physician order requires modifier EY.<\/li>\n\n\n\n<li><strong>Iron status and transfusion history:<\/strong> LCDs expect iron stores to be assessed before and during ESA therapy. Record those results alongside the hemoglobin trend.<\/li>\n\n\n\n<li><strong>Response monitoring:<\/strong> Check Hgb at least every 4 weeks during dose adjustment, then every 1 to 3 months on stable therapy. Document each result.<\/li>\n\n\n\n<li><strong>Dosing rationale:<\/strong> If the dose is escalated, the chart must explain why the clinical response was insufficient at the prior dose.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Practices that use <a href=\"https:\/\/pabau.com\/features\/patient-intake-software\/\">digital forms<\/a> can build ESA monitoring templates into the patient workflow. Each element above gets captured at the visit rather than reconstructed months later. Storage rules for those records sit under <a href=\"https:\/\/pabau.com\/blog\/hipaa-compliance-for-medical-offices\/\">HIPAA-compliant clinical documentation<\/a>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j0885\/digital-forms.webp\" alt=\"Pabau medical form template library with a patient-facing form preview\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&#8217;s form builder turns the J0885 documentation list into a template your team completes at every ESA visit.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 id=\"h-prior-authorization-and-utilization-management\" class=\"wp-block-heading\">Prior authorization and utilization management<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Traditional Medicare Part B does not require prior authorization for J0885, though Medicare Advantage plans often do. Commercial requirements vary by plan and formulary year. Never assume PA is unnecessary without checking the individual plan&#8217;s policy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Step therapy is common in commercial plans. Payers may require documented inadequate response to a biosimilar such as Retacrit before approving Epogen or Procrit. Send the hemoglobin trend, the diagnosis, and the ordered dose with the request, since those are what the reviewer checks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PA submissions send protected health information to the payer, so the usual <a href=\"https:\/\/pabau.com\/blog\/patient-data-security-tools\/\">patient data security<\/a> rules apply. <a href=\"https:\/\/pabau.com\/features\/automated-workflows-software\/\">Automated billing workflows<\/a> can flag claims that need PA before they reach submission.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j0885\/automated-communication-in-pabau.webp\" alt=\"Pabau appointment panel alongside automated client communication triggers\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&#8217;s automated communications send confirmations and pre-treatment instructions, so every ESA dose stays on schedule and on the record.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 id=\"h-j0885-vs-the-other-esa-codes-j0881-and-q4081\" class=\"wp-block-heading\">J0885 vs. the other ESA codes: J0881 and Q4081<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Using J0885 for an ESRD patient, or Q4081 for a non-ESRD patient, creates a compliance problem as well as a likely denial. The table below maps the correct code by drug, indication, and setting. Billing teams covering both nephrology and oncology should read it closely.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">HCPCS code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Drug<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Indication<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Setting<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Unit<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J0885<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Epoetin alfa<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-ESRD (CIA, CKD, HIV)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Physician office, outpatient<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 1,000 units<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Q4081<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Epoetin alfa<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ESRD on dialysis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Any dialysis setting, including home<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 100 units<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J0881<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Darbepoetin alfa<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-ESRD (CIA, CKD)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Physician office, outpatient<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 1 mcg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">There is no separate epoetin alfa code for home dialysis. Q4081 covers ESRD dialysis patients wherever the drug is given, including at home.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Take one 10,000-unit dose and run it through both epoetin alfa codes. Under J0885 you report 10 units. Under Q4081 the same dose is 100 units, because that descriptor counts in hundreds. Same drug, same syringe, and a claim line that differs by a factor of 10.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">J0881 is a different drug again, billed per microgram rather than per unit. The CMS annual CPT\/HCPCS code list confirms the current status and definition of each ESA code every fiscal year.<\/p>\n\n\n\n<h2 id=\"h-common-billing-errors-and-denial-reasons\" class=\"wp-block-heading\">Common billing errors and denial reasons<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">ESA claims are a frequent target of Medicare audits. These are the denial patterns billing teams hit most often with J0885.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Wrong code (ESRD vs non-ESRD):<\/strong> Using J0885 for a dialysis patient. Check the patient&#8217;s ESRD status in the record before every claim cycle.<\/li>\n\n\n\n<li><strong>Incorrect units:<\/strong> Billing per vial rather than per 1,000 administered units. Tie billed units to the documented administered dose, not the vial size purchased.<\/li>\n\n\n\n<li><strong>Wrong unit descriptor on a related code:<\/strong> Carrying J0885&#8217;s per-1,000-units math onto a Q4081 or J0881 line. Each ESA code counts differently, so recalculate every time.<\/li>\n\n\n\n<li><strong>Missing or incorrect route modifier:<\/strong> Omitting JA or JB. Most Medicare Administrative Contractors (MACs) require a route modifier and return claims without one.<\/li>\n\n\n\n<li><strong>Hgb above threshold:<\/strong> Billing J0885 when the documented Hgb is at or above the CMS coverage threshold. Review the latest result before submission, then attach modifier GZ or obtain a signed ABN.<\/li>\n\n\n\n<li><strong>Unsupported or absent diagnosis code:<\/strong> Submitting J0885 with a diagnosis that is not on the covered list. An anemia code sent without the underlying malignancy or CKD code fails the same way.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The habits that prevent these errors carry across every Part B item you bill, from J-codes through to equipment codes like <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-e0607\/\">E0607<\/a>. <a href=\"https:\/\/pabau.com\/blog\/ehr-integration\/\">EHR integration for billing accuracy<\/a> is what stops them being rebuilt by hand each month.<\/p>\n\n\n\n<h2 id=\"h-how-pabau-catches-j0885-errors-before-submission\" class=\"wp-block-heading\">How Pabau catches J0885 errors before submission<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A units error on J0885 usually surfaces when the remittance advice comes back. The claim was keyed from a vial count, and nobody checked it against the administration note. Fixing it costs more time than the original entry ever did.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau is an all-in-one practice management system that keeps the clinical record and the claim in the same place. The dose your clinician charts is the dose your biller sees, so a 10,000-unit administration never becomes one vial on the claim line.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&#8217;s <a href=\"https:\/\/pabau.com\/features\/claims-management-software\/\">claims management software<\/a> checks each line before it goes out. A J0885 claim with no route modifier gets flagged inside the practice instead of by the payer. The hemoglobin that justifies the dose is already attached to the visit.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The outcome is fewer reworked claims and faster payment on a drug your practice has already bought and administered.<\/p>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Catch J0885 errors before the payer does                <\/h3>\n\n                <p class=\"description\">\n                    Pabau&#8217;s claims management tools help oncology and nephrology practices track J0885 units, flag missing modifiers, and run documentation checks before claims are submitted.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau claims management dashboard\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 id=\"h-conclusion\" class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J0885 is not a hard code to bill correctly. It asks for the same three things every time. Divide the administered dose by 1,000, add the route modifier, and record the hemoglobin that supports the therapy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">What makes it expensive is how easy each of those steps is to skip when a claim is keyed from memory. The unit descriptor is the one to watch hardest, because J0885, Q4081, and J0881 all count differently for what looks like the same treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Build the three checks into the workflow once and the denials stop arriving in batches. <a href=\"https:\/\/pabau.com\/book-demo\/\">Book a demo<\/a> to see how Pabau validates HCPCS units and modifiers before your claims go out.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Losing revenue to claim denials?<\/strong> <a href=\"https:\/\/pabau.com\/blog\/claims-management-software-pabau-vs-waystar\/\">Claims management software: Pabau vs. Waystar<\/a> compares how the two platforms scrub, submit, and chase drug administration claims.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Want to reduce manual errors in clinical documentation?<\/strong> <a href=\"https:\/\/pabau.com\/features\/ai-medical-scribe\/\">Pabau Scribe, our AI scribe<\/a> structures consultation notes automatically, keeping hemoglobin monitoring records consistent and audit-ready.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing the chemotherapy administration alongside the drug?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-96401\/\">CPT code 96401<\/a> sets out the administration rules that sit next to J0885 on an oncology claim.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing other per-unit injectables?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0153\/\">J0153<\/a> walks through a descriptor with its own unit math and its own rounding traps.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need a wider view of Part B drug billing?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0561\/\">J0561<\/a> covers coverage criteria, documentation, and the quarterly ASP rate cycle for another Part B injectable.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-frequently-asked-questions\" class=\"wp-block-heading\">Frequently asked questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1786603198882\"><h3 class=\"schema-faq-question\">What is HCPCS Code J0885 used for?<\/h3> <p class=\"schema-faq-answer\">HCPCS code J0885 is used to bill injections of epoetin alfa in non-ESRD patients, billed per 1,000 units administered. Covered indications include chemotherapy-induced anemia, anemia of non-dialysis chronic kidney disease, and AZT-related anemia in HIV patients under Medicare Part B.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603198883\"><h3 class=\"schema-faq-question\">What is the difference between J0885 and J0881?<\/h3> <p class=\"schema-faq-answer\">J0885 covers epoetin alfa (Epogen, Procrit) billed per 1,000 units, while J0881 covers darbepoetin alfa (Aranesp) billed per 1 microgram. Both treat non-ESRD anemia, but they are different drugs with different dosing structures and cannot be substituted for each other on claims.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603198884\"><h3 class=\"schema-faq-question\">How do you calculate units for J0885?<\/h3> <p class=\"schema-faq-answer\">Divide the dose administered in units by 1,000 to get the number of billing units. A 10,000-unit dose is 10 billing units. Always base the calculation on the administered dose recorded in the physician order or administration note, not the vial size.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603198888\"><h3 class=\"schema-faq-question\">Why do J0885 and Q4081 report different unit counts?<\/h3> <p class=\"schema-faq-answer\">The two codes use different descriptors for the same drug. J0885 is defined per 1,000 units and Q4081 is defined per 100 units. A 10,000-unit dose is therefore 10 units of J0885 or 100 units of Q4081, so recalculate whenever the code changes.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603198885\"><h3 class=\"schema-faq-question\">What modifiers are used with HCPCS Code J0885?<\/h3> <p class=\"schema-faq-answer\">Modifier JA (intravenous administration) or JB (subcutaneous administration) is required on most J0885 claims to indicate the route. Modifier GA is added when a signed Advance Beneficiary Notice (ABN) is on file. Modifier GZ is used when the service is expected to be denied as not medically necessary.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603198886\"><h3 class=\"schema-faq-question\">Does Medicare cover J0885 for chemotherapy-induced anemia?<\/h3> <p class=\"schema-faq-answer\">Yes. Medicare Part B covers J0885 for chemotherapy-induced anemia in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy. The documented hemoglobin has to sit below the CMS coverage threshold, and the chart must carry the covered diagnosis and a signed order.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603198887\"><h3 class=\"schema-faq-question\">Is prior authorization required for J0885?<\/h3> <p class=\"schema-faq-answer\">Traditional Medicare Part B does not require prior authorization for J0885, but many Medicare Advantage and commercial plans do. Requirements vary by payer and plan year, so verify the plan&#8217;s PA policy before each treatment course. Step therapy against a biosimilar is common in commercial plans.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>J0885 covers epoetin alfa for non-dialysis patients, billed per 1,000 units. Add modifier JA or JB, and pair D63.1 with a CKD stage code.<\/p>\n","protected":false},"author":83,"featured_media":177158,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"84","_yoast_wpseo_content_score":"30","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1433,1548],"tags":[2957,1619,2953,2959],"class_list":["post-177159","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-billing-codes","category-hcpcs","tag-drug-administration-billing","tag-hcpcs-billing","tag-j-code-billing","tag-medicare-part-b-drugs"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HCPCS Code J0885: Units, modifiers, and non-ESRD rules<\/title>\n<meta name=\"description\" content=\"J0885 covers epoetin alfa for non-dialysis patients, billed per 1,000 units. Add modifier JA or JB, and pair D63.1 with a CKD stage code.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HCPCS Code J0885: Units, modifiers, and non-ESRD rules\" \/>\n<meta property=\"og:description\" content=\"J0885 covers epoetin alfa for non-dialysis patients, billed per 1,000 units. Add modifier JA or JB, and pair D63.1 with a CKD stage code.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-13T08:40:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-13T08:40:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0885.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Anja Dodevska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anja Dodevska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"12\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/\"},\"author\":{\"name\":\"Anja Dodevska\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/person\\\/f2e43b25ed02313e8781f0f4507398b9\"},\"headline\":\"HCPCS Code J0885: Epoetin alfa billing guide for non-ESRD use\",\"datePublished\":\"2026-08-13T08:40:13+00:00\",\"dateModified\":\"2026-08-13T08:40:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/\"},\"wordCount\":2412,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0885.webp\",\"keywords\":[\"Drug Administration Billing\",\"Hcpcs Billing\",\"J Code Billing\",\"Medicare Part B Drugs\"],\"articleSection\":[\"Billing Codes\",\"HCPCS\"],\"inLanguage\":\"de\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/\",\"name\":\"HCPCS Code J0885: Units, modifiers, and non-ESRD rules\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0885.webp\",\"datePublished\":\"2026-08-13T08:40:13+00:00\",\"dateModified\":\"2026-08-13T08:40:16+00:00\",\"description\":\"J0885 covers epoetin alfa for non-dialysis patients, billed per 1,000 units. Add modifier JA or JB, and pair D63.1 with a CKD stage code.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198882\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198883\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198884\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198888\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198885\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198886\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198887\"}],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0885.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0885.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/person\\\/f2e43b25ed02313e8781f0f4507398b9\",\"name\":\"Anja Dodevska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"caption\":\"Anja Dodevska\"},\"description\":\"Anja Dodevska writes about healthcare, dermatology, and the day-to-day realities of running a medical practice for Pabau. She enjoys breaking down complex topics into clear, accessible content and has a soft spot for the often-overlooked aspects of clinic life. When she's not writing, she's exploring cafes, walking her dog, or spending time with friends and family.\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/blog\\\/author\\\/anja-dodevska\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198882\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198882\",\"name\":\"What is HCPCS Code J0885 used for?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"HCPCS code J0885 is used to bill injections of epoetin alfa in non-ESRD patients, billed per 1,000 units administered. Covered indications include chemotherapy-induced anemia, anemia of non-dialysis chronic kidney disease, and AZT-related anemia in HIV patients under Medicare Part B.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198883\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198883\",\"name\":\"What is the difference between J0885 and J0881?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J0885 covers epoetin alfa (Epogen, Procrit) billed per 1,000 units, while J0881 covers darbepoetin alfa (Aranesp) billed per 1 microgram. Both treat non-ESRD anemia, but they are different drugs with different dosing structures and cannot be substituted for each other on claims.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198884\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198884\",\"name\":\"How do you calculate units for J0885?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divide the dose administered in units by 1,000 to get the number of billing units. A 10,000-unit dose is 10 billing units. Always base the calculation on the administered dose recorded in the physician order or administration note, not the vial size.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198888\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198888\",\"name\":\"Why do J0885 and Q4081 report different unit counts?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The two codes use different descriptors for the same drug. J0885 is defined per 1,000 units and Q4081 is defined per 100 units. A 10,000-unit dose is therefore 10 units of J0885 or 100 units of Q4081, so recalculate whenever the code changes.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198885\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198885\",\"name\":\"What modifiers are used with HCPCS Code J0885?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Modifier JA (intravenous administration) or JB (subcutaneous administration) is required on most J0885 claims to indicate the route. Modifier GA is added when a signed Advance Beneficiary Notice (ABN) is on file. Modifier GZ is used when the service is expected to be denied as not medically necessary.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198886\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198886\",\"name\":\"Does Medicare cover J0885 for chemotherapy-induced anemia?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. Medicare Part B covers J0885 for chemotherapy-induced anemia in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy. The documented hemoglobin has to sit below the CMS coverage threshold, and the chart must carry the covered diagnosis and a signed order.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198887\",\"position\":7,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j0885\\\/#faq-question-1786603198887\",\"name\":\"Is prior authorization required for J0885?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Traditional Medicare Part B does not require prior authorization for J0885, but many Medicare Advantage and commercial plans do. Requirements vary by payer and plan year, so verify the plan's PA policy before each treatment course. Step therapy against a biosimilar is common in commercial plans.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HCPCS Code J0885: Units, modifiers, and non-ESRD rules","description":"J0885 covers epoetin alfa for non-dialysis patients, billed per 1,000 units. Add modifier JA or JB, and pair D63.1 with a CKD stage code.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/","og_locale":"de_DE","og_type":"article","og_title":"HCPCS Code J0885: Units, modifiers, and non-ESRD rules","og_description":"J0885 covers epoetin alfa for non-dialysis patients, billed per 1,000 units. Add modifier JA or JB, and pair D63.1 with a CKD stage code.","og_url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-08-13T08:40:13+00:00","article_modified_time":"2026-08-13T08:40:16+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0885.webp","type":"image\/webp"}],"author":"Anja Dodevska","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"Verfasst von":"Anja Dodevska","Gesch\u00e4tzte Lesezeit":"12\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/"},"author":{"name":"Anja Dodevska","@id":"https:\/\/pabau.com\/de\/#\/schema\/person\/f2e43b25ed02313e8781f0f4507398b9"},"headline":"HCPCS Code J0885: Epoetin alfa billing guide for non-ESRD use","datePublished":"2026-08-13T08:40:13+00:00","dateModified":"2026-08-13T08:40:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/"},"wordCount":2412,"publisher":{"@id":"https:\/\/pabau.com\/de\/#organization"},"image":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0885.webp","keywords":["Drug Administration Billing","Hcpcs Billing","J Code Billing","Medicare Part B Drugs"],"articleSection":["Billing Codes","HCPCS"],"inLanguage":"de"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/","url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/","name":"HCPCS Code J0885: Units, modifiers, and non-ESRD rules","isPartOf":{"@id":"https:\/\/pabau.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0885.webp","datePublished":"2026-08-13T08:40:13+00:00","dateModified":"2026-08-13T08:40:16+00:00","description":"J0885 covers epoetin alfa for non-dialysis patients, billed per 1,000 units. Add modifier JA or JB, and pair D63.1 with a CKD stage code.","mainEntity":[{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198882"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198883"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198884"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198888"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198885"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198886"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198887"}],"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0885.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0885.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/de\/#website","url":"https:\/\/pabau.com\/de\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/pabau.com\/de\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/de\/#\/schema\/person\/f2e43b25ed02313e8781f0f4507398b9","name":"Anja Dodevska","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","caption":"Anja Dodevska"},"description":"Anja Dodevska writes about healthcare, dermatology, and the day-to-day realities of running a medical practice for Pabau. She enjoys breaking down complex topics into clear, accessible content and has a soft spot for the often-overlooked aspects of clinic life. When she's not writing, she's exploring cafes, walking her dog, or spending time with friends and family.","url":"https:\/\/pabau.com\/de\/blog\/author\/anja-dodevska\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198882","position":1,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198882","name":"What is HCPCS Code J0885 used for?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"HCPCS code J0885 is used to bill injections of epoetin alfa in non-ESRD patients, billed per 1,000 units administered. Covered indications include chemotherapy-induced anemia, anemia of non-dialysis chronic kidney disease, and AZT-related anemia in HIV patients under Medicare Part B.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198883","position":2,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198883","name":"What is the difference between J0885 and J0881?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J0885 covers epoetin alfa (Epogen, Procrit) billed per 1,000 units, while J0881 covers darbepoetin alfa (Aranesp) billed per 1 microgram. Both treat non-ESRD anemia, but they are different drugs with different dosing structures and cannot be substituted for each other on claims.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198884","position":3,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198884","name":"How do you calculate units for J0885?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Divide the dose administered in units by 1,000 to get the number of billing units. A 10,000-unit dose is 10 billing units. Always base the calculation on the administered dose recorded in the physician order or administration note, not the vial size.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198888","position":4,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198888","name":"Why do J0885 and Q4081 report different unit counts?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The two codes use different descriptors for the same drug. J0885 is defined per 1,000 units and Q4081 is defined per 100 units. A 10,000-unit dose is therefore 10 units of J0885 or 100 units of Q4081, so recalculate whenever the code changes.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198885","position":5,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198885","name":"What modifiers are used with HCPCS Code J0885?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Modifier JA (intravenous administration) or JB (subcutaneous administration) is required on most J0885 claims to indicate the route. Modifier GA is added when a signed Advance Beneficiary Notice (ABN) is on file. Modifier GZ is used when the service is expected to be denied as not medically necessary.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198886","position":6,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198886","name":"Does Medicare cover J0885 for chemotherapy-induced anemia?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes. Medicare Part B covers J0885 for chemotherapy-induced anemia in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy. The documented hemoglobin has to sit below the CMS coverage threshold, and the chart must carry the covered diagnosis and a signed order.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198887","position":7,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j0885\/#faq-question-1786603198887","name":"Is prior authorization required for J0885?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Traditional Medicare Part B does not require prior authorization for J0885, but many Medicare Advantage and commercial plans do. Requirements vary by payer and plan year, so verify the plan's PA policy before each treatment course. Step therapy against a biosimilar is common in commercial plans.","inLanguage":"de"},"inLanguage":"de"}]}},"yoast":{"focus_keyword":"HCPCS code J0885","seo_title":"HCPCS Code J0885: Units, modifiers, and non-ESRD rules","meta_description":"J0885 covers epoetin alfa for non-dialysis patients, billed per 1,000 units. Add modifier JA or JB, and pair D63.1 with a CKD stage code.","content_score":"30","is_cornerstone":"","related_keyphrases":[{"keyword":"erythropoiesis stimulating agent billing","score":61},{"keyword":"chemotherapy anemia billing","score":61},{"keyword":"epoetin alfa Medicare Part B","score":61}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/177159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/users\/83"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/comments?post=177159"}],"version-history":[{"count":3,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/177159\/revisions"}],"predecessor-version":[{"id":177487,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/177159\/revisions\/177487"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/media\/177158"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/media?parent=177159"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/categories?post=177159"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/tags?post=177159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}